MX2010004620A - Derivados de benzomorfolina y metodos de uso. - Google Patents

Derivados de benzomorfolina y metodos de uso.

Info

Publication number
MX2010004620A
MX2010004620A MX2010004620A MX2010004620A MX2010004620A MX 2010004620 A MX2010004620 A MX 2010004620A MX 2010004620 A MX2010004620 A MX 2010004620A MX 2010004620 A MX2010004620 A MX 2010004620A MX 2010004620 A MX2010004620 A MX 2010004620A
Authority
MX
Mexico
Prior art keywords
methods
diseases
compounds
prophylaxis
processes
Prior art date
Application number
MX2010004620A
Other languages
English (en)
Spanish (es)
Inventor
Raju Subramanian
Jean-Christophe Harmange
Matthew W Martin
Ryan White
Roger Zanon
Jay Larrow
Yohannes Teffera
Joseph F Payack
Mina Dilmeghani Seran
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX2010004620A publication Critical patent/MX2010004620A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2010004620A 2007-10-29 2008-10-28 Derivados de benzomorfolina y metodos de uso. MX2010004620A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94807P 2007-10-29 2007-10-29
PCT/US2008/012224 WO2009058267A2 (en) 2007-10-29 2008-10-28 Benzomorpholine derivatives and methods of use

Publications (1)

Publication Number Publication Date
MX2010004620A true MX2010004620A (es) 2010-07-28

Family

ID=40394086

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004620A MX2010004620A (es) 2007-10-29 2008-10-28 Derivados de benzomorfolina y metodos de uso.

Country Status (8)

Country Link
US (1) US7795254B2 (enExample)
EP (1) EP2220078B1 (enExample)
JP (1) JP5343082B2 (enExample)
AU (1) AU2008319366B2 (enExample)
CA (1) CA2703257C (enExample)
ES (1) ES2417009T3 (enExample)
MX (1) MX2010004620A (enExample)
WO (1) WO2009058267A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684182A5 (de) 1991-10-15 1994-07-29 Escher Wyss Ag Rotationsdruckmaschine.
WO2011144656A1 (en) * 2010-05-19 2011-11-24 Sandoz Ag Preparation of posaconazole intermediates
WO2011144655A1 (en) 2010-05-19 2011-11-24 Sandoz Ag Process for the preparation of chiral hydrazides
CA2798010C (en) 2010-05-19 2018-09-25 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
CN108329303A (zh) 2011-06-16 2018-07-27 桑多斯股份公司 制备手性化合物的方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755332A (en) * 1971-07-01 1973-08-28 Ciba Geigy Corp Substituted 4 indazolaminoquinolines
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
GB9323290D0 (en) * 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
AU4547396A (en) 1995-01-31 1996-08-21 Zenyaku Kogyo Kabushiki Kaisha Thioquinoline derivatives
GB9505702D0 (en) 1995-03-21 1995-05-10 Agrevo Uk Ltd Fungicidal compounds
GB9505651D0 (en) 1995-03-21 1995-05-10 Agrevo Uk Ltd AgrEvo UK Limited
GB9514265D0 (en) 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
EP0860433B1 (en) * 1995-11-07 2002-07-03 Kirin Beer Kabushiki Kaisha Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
WO1997018212A1 (en) * 1995-11-14 1997-05-22 Pharmacia & Upjohn S.P.A. Aryl and heteroaryl purine compounds
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
DE19614718A1 (de) * 1996-04-15 1997-10-16 Hoechst Schering Agrevo Gmbh Substituierte Pyridine/Pyrimidine, Verfahren zu ihrer Herstellung, und ihre Verwendung als Schädlingsbekämpfungsmittel
GB9800575D0 (en) 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
ATE293102T1 (de) * 1998-04-23 2005-04-15 Takeda Pharmaceutical Naphthalene derivate ,ihre herstellung und verwendung
KR20010089171A (ko) * 1998-08-21 2001-09-29 추후제출 퀴나졸린 유도체
BRPI0017548B8 (pt) * 1999-02-10 2023-05-02 Astrazeneca Ab Composto
US6258820B1 (en) * 1999-03-19 2001-07-10 Parker Hughes Institute Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
NZ514602A (en) * 1999-04-12 2003-06-30 Aventis Pharma Ltd Substituted bicyclic heteroaryl compounds as integrin antagonists
US6849625B2 (en) * 2000-10-13 2005-02-01 Astrazeneca Ab Quinazoline derivatives with anti-tumour activity
WO2002032872A1 (fr) * 2000-10-20 2002-04-25 Eisai Co., Ltd. Composes a noyau aromatique azote
KR100883731B1 (ko) * 2001-06-22 2009-02-12 기린 파마 가부시끼가이샤 간세포 증식 인자 수용체 자기 인산화를 저해하는 퀴놀린유도체 및 퀴나졸린 유도체 및 이들을 함유하는 의약 조성물
JP2005515176A (ja) * 2001-11-03 2005-05-26 アストラゼネカ アクチボラグ 抗腫瘍剤としてのキナゾリン誘導体
GB0126433D0 (en) * 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
CN1625555A (zh) * 2002-02-01 2005-06-08 阿斯特拉曾尼卡有限公司 喹唑啉化合物
US7645878B2 (en) * 2002-03-22 2010-01-12 Bayer Healthcare Llc Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
JP4628678B2 (ja) * 2002-03-29 2011-02-09 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 置換ベンズアゾールおよびＲａｆキナーゼ阻害剤としてのそれらの使用
AU2003257666A1 (en) * 2002-08-23 2004-03-11 Kirin Beer Kabushiki Kaisha COMPOUND HAVING TGFss INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
WO2004078114A2 (en) * 2003-02-28 2004-09-16 Encysive Pharmaceuticals Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists.
US7320989B2 (en) * 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
US7531553B2 (en) * 2003-03-21 2009-05-12 Amgen Inc. Heterocyclic compounds and methods of use
GB0310401D0 (en) * 2003-05-07 2003-06-11 Astrazeneca Ab Therapeutic agent
US7312330B2 (en) * 2003-12-24 2007-12-25 Renovis, Inc. Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
CN1933839A (zh) * 2004-01-23 2007-03-21 安进公司 化合物和使用方法
JO2787B1 (en) * 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use

Also Published As

Publication number Publication date
CA2703257C (en) 2013-02-19
WO2009058267A3 (en) 2010-06-10
EP2220078A2 (en) 2010-08-25
US20090149454A1 (en) 2009-06-11
JP2011502147A (ja) 2011-01-20
US7795254B2 (en) 2010-09-14
ES2417009T3 (es) 2013-08-05
EP2220078B1 (en) 2013-05-22
WO2009058267A2 (en) 2009-05-07
CA2703257A1 (en) 2009-05-07
AU2008319366B2 (en) 2012-03-01
AU2008319366A1 (en) 2009-05-07
JP5343082B2 (ja) 2013-11-13

Similar Documents

Publication Publication Date Title
MX2010007683A (es) Derivados heterociclicos fusionados y metodos de uso como inhibidores de c-met.
MY167135A (en) Fused heterocyclic derivatives and methods of use
MX2009006543A (es) Compuestos heterociclicos y su uso en el tratamiento de la inflamacion, angiogenesis y cancer.
WO2008086014A3 (en) Bis-aryl amide derivatives useful for the treatment of cancer
MX2009008531A (es) Cetonas de heterociclilo que contienen nitrogeno y su uso como inhibidores de c-met.
TW200716596A (en) Substituted amide derivatives and methods of use
WO2008079291A3 (en) Substituted heterocycles and methods of use
TNSN06228A1 (en) Compounds and methods of use
WO2007048070A3 (en) Pyrrolo-pyridine derivatives for the treatment of cancer diseases
ATE404552T1 (de) Substituierte isochinolinderivate und anwendungsverfahren
WO2007005668A3 (en) Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer
ATE453636T1 (de) Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren
MX2012000565A (es) Derivados de triterpeno tipo lupeol como antivirales.
WO2004005279A3 (en) Substituted anthranilic amide derivatives and methods of use
IN2012DN00971A (enExample)
ATE540038T1 (de) Heterocyclen als proteinkinaseinhibitoren
GEP20135806B (en) Lactams as beta secretase inhibitors
IL172419A0 (en) Piperazine derivatives and methods of use
MX2012001134A (es) Composiciones y metodos para inhibicion de la via jak.
WO2009109501A3 (en) Ocular pharmaceutical compositions
IN2013DN02555A (enExample)
MX2010004620A (es) Derivados de benzomorfolina y metodos de uso.
MX339619B (es) Formulaciones, sales y polimorfos de transnorsertralina y usos de los mismos.
PH12012501476A1 (en) Aminoquinoline derivatives
WO2006041888A3 (en) Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents

Legal Events

Date Code Title Description
FG Grant or registration